Enanta Pharmaceuticals Inc.
ENTA | NASDAQ
$12.20
+$0.09 (+0.74%)
Sep 22, 2026, 11:59 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Sep 29, 2025 | FY 2024 Sep 29, 2024 | FY 2023 Sep 29, 2023 | FY 2022 Sep 29, 2022 | FY 2021 Sep 29, 2021 | FY 2020 Sep 29, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 32.3M | 37.23M | 85.39M | 43.99M | 57.21M | 87.13M |
Short-Term Investments | 156.57M | 210.95M | 284.52M | 205.24M | 186.8M | 299.52M |
Long-Term Investments | 3.36M | 3.36M | 3.97M | 33.25M | 109.02M | 33.24M |
Other Long-Term Assets | 92K | 94K | 803K | 696K | 92K | 92K |
Receivables | 6.88M | 38.65M | 39.62M | 49.04M | 60.83M | 23.49M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 8.59M | 608K | 13.26M | n/a | n/a | 26.7M |
Total Current Assets | 204.34M | 299.85M | 422.79M | 311.71M | 319.02M | 436.84M |
Property-Plant & Equipment | 72.94M | 73.35M | 34.71M | 29.75M | 10.65M | 15.62M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 76.4M | 76.8M | 39.48M | 68.88M | 121.84M | 53.95M |
Total Assets | 280.73M | 376.65M | 462.28M | 380.59M | 440.86M | 490.79M |
Account Payables | 1.95M | 8M | 4.1M | 6M | 9.54M | 5.74M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 30.71M | 34.46M | n/a | n/a | n/a | 4.26M |
Other Current Liabilities | n/a | n/a | 35.08M | 14.5M | 16.34M | 9.38M |
Total Current Liabilities | 48.56M | 57.54M | 62.79M | 29.83M | 36.17M | 24.16M |
Long-Term Debt | 112.44M | 136.13M | n/a | 1.42M | 1.51M | 1.48M |
Other Long-Term Liabilities | 260K | 231K | 161.52M | 454K | 558K | 1.08M |
Total Long-Term Liabilities | 167.46M | 190.3M | 182.75M | 29.43M | 5.26M | 11.05M |
Total Liabilities | 216.02M | 247.84M | 245.54M | 59.26M | 41.43M | 35.21M |
Total Debt | 201.06M | 226.06M | 26.51M | 26.69M | 6.84M | 9.58M |
Book Value | 64.72M | 128.81M | 216.74M | 321.33M | 399.43M | 455.58M |
Book Value Per Share | 3.03 | 6.09 | 10.34 | 15.60 | 19.80 | 22.85 |
Common Stock | 214K | 212K | 211K | 208K | 202K | 201K |
Retained Earnings | -404.93M | -323.04M | -207M | -73.18M | 48.58M | 127.57M |
Comprehensive Income | -339K | 302K | -1.17M | -3.72M | -382K | 844K |
Shareholders Equity | 64.72M | 128.81M | 216.74M | 321.33M | 399.43M | 455.58M |
Total Investments | 159.93M | 214.31M | 288.49M | 238.49M | 295.82M | 332.76M |
Add to Watchlist
Select watchlists to add or remove ENTA